Back to top
more

West Pharmaceutical Services (WST)

(Real Time Quote from BATS)

$318.17 USD

318.17
49,510

+0.15 (0.05%)

Updated Jul 23, 2024 10:20 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (160 out of 250)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Varian Expands Access to Advanced Cancer Treatment With Ethos

by Zacks Equity Research

Varian's (VAR) Ethos Therapy used by Goshen Center for Cancer Care marks the expansion access to personalized cancer care.

PRA Health (PRAH) Inks Deal With Leukemia & Lymphoma Society

by Zacks Equity Research

PRA Health (PRAH) partners with LLS to bring new treatments for children with relapsed acute leukemia.

Here's Why You Should Hold on to Nevro (NVRO) Stock Now

by Zacks Equity Research

Nevro (NVRO) continues to gain traction from Senza, its flagship platform, and R&D capabilities. However, stiff competition remains a woe.

Varian's Halcyon System to Bring Improved Care to Singapore

by Zacks Equity Research

Varian (VAR) strengthens its partnership Proton Therapy Pte as it brings improved care to Singapore through Halcyon system.

NextGen Healthcare Introduces New Behavioral Health Suite

by Zacks Equity Research

NextGen Healthcare's (NXGN) new behavioral health suite aims to provide whole person care with support services for healthcare providers and clinicians.

Cooper Companies (COO) Q3 Earnings & Revenues Top Estimates

by Zacks Equity Research

Cooper Companies' (COO) fiscal third-quarter earnings reflect dismal segmental performance. However, it exceeded expectation as it witnessed faster-than-anticipated recovery.

Top Ranked Growth Stocks to Buy for September 4th

by Zacks Equity Research

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, September 4th.

Aurora Cannabis (ACB) to Post Q4 Earnings: What's in Store?

by Zacks Equity Research

Aurora Cannabis' (ACB) fiscal fourth-quarter results likely to reflect solid prospects in the Canadian market.

Patterson Companies (PDCO) Q1 Earnings Top Estimates, Up Y/Y

by Zacks Equity Research

Despite weak performance across Patterson Companies' (PDCO) Dental and Animal Health segments in the fiscal first quarter results, it benefited from aggressive cost savings measures.

Zacks.com featured highlights include: Kinsale Capital, American States Water, Gibraltar Industries, D.R. Horton and West Pharmaceutical

by Zacks Equity Research

Zacks.com featured highlights include: Kinsale Capital, American States Water, Gibraltar Industries, D.R. Horton and West Pharmaceutical

Aparajita Dutta headshot

Buy These 5 Low Leverage Stocks Amid Ongoing Economic Crisis

by Aparajita Dutta

As the global economy is still topsy turvy, thanks to the coronavirus pandemic, investors should be even more careful while choosing stocks

What's in Store for Patterson Companies' (PDCO) Q1 Earnings?

by Zacks Equity Research

Patterson Companies' (PDCO) fiscal first-quarter results are likely to reflect sluggishness at Dental segment.

Here's Why You Should Invest in LHC Group (LHCG) Stock Now

by Zacks Equity Research

LHC Group (LHCG) continues to gain traction from its broad range of services, and strategic acquisitions and joint ventures.

Cooper Companies (COO) to Post Q3 Earnings: What's in Store?

by Zacks Equity Research

Cooper Companies' (COO) fiscal third-quarter performance is likely to reflect weak performance by CVI and CSI.

Is West Pharmaceutical Services (WST) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (WST) Outperforming Other Medical Stocks This Year?

Hologic Updates Breast Biopsy System to Enhance Workflow

by Zacks Equity Research

Hologic (HOLX) introduces features to update Brevera Breast Biopsy System in order to transform patient experience and enhance workflow.

Phibro (PAHC) Q4 Earnings Fall Short of Estimates, Margins Up

by Zacks Equity Research

Phibro's (PAHC) core Animal Health segment was aided by the Osprey Biotechnics acquisition despite a dismal overall performance in Q4 due to pandemic-led business disruptions.

AMN Healthcare's Advanced Mobile App to Aid Travel Clinicians

by Zacks Equity Research

AMN Healthcare's (AMN) new version of AMN Passport will benefit travel clinicians.

Allscripts Enhances Healthcare Innovation With Patent Program

by Zacks Equity Research

Allscripts (MDRX) continues to advance healthcare innovation by earning five new application patents.

Here's Why You Should Hold on to DENTSPLY (XRAY) Stock Now

by Zacks Equity Research

DENTSPLY (XRAY) continues to gain traction from its solid focus on R&D leading to product innovation, which continues to be a key catalyst.

Here's Why You Should Invest in Fresenius Medical Stock Now

by Zacks Equity Research

Fresenius Medical (FMS) continues to gain traction from its broad range of dialysis products and services.

Veeva Systems (VEEV) to Post Q2 Earnings: What's in Store?

by Zacks Equity Research

Veeva Systems' (VEEV) fiscal second-quarter results are likely to reflect solid show by its segments and robust product portfolio.

Here's Why You Should Retain Cardinal Health Stock for Now

by Zacks Equity Research

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment, diversified product portfolio and strategic buyouts.

Aparajita Dutta headshot

Buy These 5 Low Leverage Stocks to Weather Coronavirus Impact

by Aparajita Dutta

With the Q2 reporting cycle drawing to a close, investors must be eyeing stocks that exhibited solid earnings growth in the prior quarters. But choosing stocks with high debt level might be risky.

Allscripts' Collaboration to Advance Healthcare Innovation

by Zacks Equity Research

Allscripts (MDRX) partners with Israel's Sheba Medical Center to help enhance healthcare innovation with smarter technology, thereby improving patient outcomes.